Timothy Dixon
Chief Executive Officer at THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Net worth: 449 350 $ as of 2024-04-29
Timothy Dixon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Chief Executive Officer | 2011-03-30 | - |
| Chairman | 2012-01-02 | - | |
| Director of Finance/CFO | - | - | |
| President | 2011-03-30 | - | |
| Director/Board Member | 2011-03-30 | 2012-01-02 | |
| Corporate Secretary | 2011-04-06 | 2012-11-06 | |
| Treasurer | 2011-04-06 | 2012-11-06 | |
| Trading-Fixed Income | 2011-04-06 | 2011-04-06 | |
| MxThree Dimensional Media Ic | President | 2011-03-30 | - |
MolecuVax, Inc.
 MolecuVax, Inc. BiotechnologyHealth Technology MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA. | Chairman | 2014-12-31 | - |
| President | 2014-12-31 | - | |
OmniBiome, Inc.
 OmniBiome, Inc. Medical SpecialtiesHealth Technology OmniBiome, Inc. manufactures diagnostic kits. It focuses on developing Dx/Rx products and services for pre-pregnancy-associated and pregnancy-associated conditions or diseases where there is a substantive putative link with microbiome dysbiosis, as well as on restoring eubiosis. The company is headquartered in Oceanside, CA. | Chairman | - | - |
| President | - | - | |
Capo Therapeutics, Inc.
 Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Capo Therapeutics, Inc. develops peptide and epitope vaccines for Alzheimer’s disease. The company is headquartered in Oceanside, CA. | Director/Board Member | - | - |
| Chairman | - | - | |
| President | - | - | |
Sandbox Dental Labs, Inc.
 Sandbox Dental Labs, Inc. Medical/Nursing ServicesHealth Services Sandbox Dental Labs, Inc. operates a dental laboratory. | Chairman | - | - |
| President | - | - |
Career history of Timothy Dixon
Former positions of Timothy Dixon
| Companies | Position | Start | End |
|---|---|---|---|
| TMD Courses, Inc. | President | 2005-12-31 | 2011-12-31 |
Splint Decisions, Inc.
 Splint Decisions, Inc. Medical SpecialtiesHealth Technology Splint Decisions, Inc. engaged in developing, producing, and marketing total splint systems. It offered NTI tension suppression systems and dental devices. The company was headquartered in Oceanside, CA. | President | 2009-12-31 | 2010-12-31 |
Emvolio, Inc.
 Emvolio, Inc. Pharmaceuticals: MajorHealth Technology Emvolio, Inc. develops cancer drugs. | Chairman | - | - |
| President | - | - |
Statistics
International
| United States | 10 |
Operational
| President | 9 |
| Chairman | 6 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 7 |
| Finance | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Health Technology |
| Private companies | 8 |
|---|---|
| TMD Courses, Inc. | Finance |
Splint Decisions, Inc.
Splint Decisions, Inc. Medical SpecialtiesHealth Technology Splint Decisions, Inc. engaged in developing, producing, and marketing total splint systems. It offered NTI tension suppression systems and dental devices. The company was headquartered in Oceanside, CA. | Health Technology |
| MxThree Dimensional Media Ic | |
OmniBiome, Inc.
OmniBiome, Inc. Medical SpecialtiesHealth Technology OmniBiome, Inc. manufactures diagnostic kits. It focuses on developing Dx/Rx products and services for pre-pregnancy-associated and pregnancy-associated conditions or diseases where there is a substantive putative link with microbiome dysbiosis, as well as on restoring eubiosis. The company is headquartered in Oceanside, CA. | Health Technology |
Capo Therapeutics, Inc.
Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Capo Therapeutics, Inc. develops peptide and epitope vaccines for Alzheimer’s disease. The company is headquartered in Oceanside, CA. | Health Technology |
MolecuVax, Inc.
MolecuVax, Inc. BiotechnologyHealth Technology MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA. | Health Technology |
Emvolio, Inc.
Emvolio, Inc. Pharmaceuticals: MajorHealth Technology Emvolio, Inc. develops cancer drugs. | Health Technology |
Sandbox Dental Labs, Inc.
Sandbox Dental Labs, Inc. Medical/Nursing ServicesHealth Services Sandbox Dental Labs, Inc. operates a dental laboratory. | Health Services |
- Stock Market
- Insiders
- Timothy Dixon
- Experience
